ApprovalTrail

Approval · Notice of Compliance 3125 · 1998

FEXICAM: Notice of Compliance 3125

Issued May 22, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3125
Date
May 22, 1998
Company
Technilab Pharma Inc.Mirabel, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Nonsteroidal anti-inflammatory, analgesic and antipyretic agent
Canadian reference product
FELDENE (Pfizer Canada Ulc)

Products in this notice

BrandDINStatus today
FEXICAM02238028Cancelled Post Market

Medicinal ingredients